International efforts in nanoinformatics research applied to nanomedicine

Methods of Information in Medicine

Volumn 50, Issue 1, 2011, Pages 84-95

  de la Iglesia, Diana ^a   Maojo, V ^a   Chiesa, S ^a   Martin Sanchez, F ^b   Kern, J ^c   Potamias, G ^d   Crespo, J ^a   Garcia Remesal, M ^a   Keuchkerian, S ^e   Kulikowski, C ^f   Mitchell, J A ^g  

^a UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d INSTITUTE OF COMPUTER SCIENCE   (Greece)

^e Health Grid Organization   (France)

^f RUTGERS UNIVERSITY   (United States)

^g UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Information management; Nanoinformatics, nanomedicine; Nanoparticles; Text mining

Indexed keywords

ARTICLE; INFORMATION SYSTEM; INTERNATIONAL COOPERATION; METHODOLOGY; NANOMEDICINE; RESEARCH;

INFORMATION MANAGEMENT; INTERNATIONALITY; NANOMEDICINE; RESEARCH;

EID: 79958823264     PISSN: 00261270     EISSN: None     Source Type: Journal    
DOI: 10.3414/ME10-02-0012     Document Type: Article

References (87)

1. Jain KK. The Handbook of Nanomedicine. 1st ed. Totowa, New Jersey: Humana; 2008.
2. Zerhouni E. Medicine: The NIH Roadmap. Science 2003; 302 (5642): 63-72. Available from: http:// dx.doi.org/10.1126\%25252Fscience.1091867.
3. National Institutes of Health, U.S. Department of Health and Human Services. The NIH Roadmap: Accelerating Medical Discovery to Improve Health (homepage on the Internet). Maryland: Division of Program Coordination, Planning, and Strategic Initiatives. Updated February 2010; cited February 6, 2010. Available from: http://nihroadmap.nih.gov/
4. Feynman R. There is plenty of room at the bottom. An Invitation to Enter a New Field of Physics. Engr & Sci 1960; 23: 22-36.
5. Buzea C, Pacheco II, Robbie K. Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases 2008; 2 (4): MR17-MR71. Available from: http:// dx.doi.org/ 10.1116/1.2815690.
6. Weber DO. Nanomedicine. Health Forum J 1999; 42 (4): 32, 36-37.
7. Douglas SJ, Davis SS, Illum L. Nanoparticles in drug delivery. Crit Rev Ther Drug Carrier Syst 1987; 3 (3): 233-261 (Review).
8. Kreuter J. Nanoparticles and nanocapsules-new dosage forms in the nanometer size range. Pharm Acta Helv 1978; 53 (2): 33-39.
9. Rogers JA. Recent developments in drug delivery. Can J Hosp Pharm 1982; 35 (6): 170-174, 196.
10. El-Samaligy MS, Rohdewald P. Reconstituted collagen nanoparticles, a novel drug carrier delivery system. J Pharm Pharmacol 1983; 35 (8): 537-539.
11. Nilsson KG. Preparation of nanoparticles conjugated with enzyme and antibody and their use in heterogeneous enzyme immunoassays. J Immunol Methods 1989; 122 (2): 273-277.
12. Violante MR. Potential of microparticles for diagnostic tracer imaging. Acta Radiol Suppl 1990; 374: 153-156 (Review).
13. James ND, Coker RJ, Tomlinson D, Harris JR, Gompels M, Pinching AJ, Stewart JS. Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS. Clin Oncol (R Coll Radiol) 1994; 6 (5): 294-296.
14. Truong-Le VL, August JT, Leong KW. Controlled gene delivery by DNA-gelatin nanospheres. Hum Gene Ther 1998; 9 (12): 1709-1717.
15. Freitas RA. Nanomedicine, Volume I: Basic Capabilities. Georgetown, Texas: Landes Bioscience 1999. Available from: http://www.nanomedicine. com/NMI.htm.
16. Bogunia-Kubik K, Sugisaka M. From molecular biology to nanotechnology and nanomedicine. Biosystems 2002; 65 (2-3): 123-138.
17. Roco MC. Nanotechnology: convergence with modern biology and medicine. Curr Op Biotechnol 2003; 14: 337-346.
18. Freitas RA. Nanomedicine, Volume IIA: Biocompatibility. Georgetown, Texas: Landes Bioscience; 2003. Available from: http://www.nanomedicine. com/NMIIA.htm.
19. Allen TM, Cullis PR. Drug Delivery Systems: Entering the Mainstream. Science 2004; 303 (5665): 1818-1822. Available from: doi:10.1126/science. 1095833
20. Jain KK, Jain V. Impact of nanotechnology on healthcare. Nanotechnol Law bus 2006; 3: 411-418.
21. Liu YY, Miyoshi H, Nakamura M. Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int J of Cancer 2007; 120 (12): 2527-2537.
22. Gewin V. Big opportunities in a small world. Nature 2009; 460 (7254): 540-541.
23. Kulikowski CA. The micro-macro spectrum of medical informatics challenges: from molecular medicine to transforming health care in a globalizing society. Methods Inf Med 2002; 41(1): 20-24.
24. Blobel B. Architectural approach to eHealth for enabling paradigm changes in health. Methods Inf Med 2010; 49 (2): 123-134
25. Transinsight GmbH. GoPubMed (homepage on the internet). Available from: http://www.gopubmed. org/. Last access: February 2010.
26. Workshop on Nanoinformatics Strategies. June 12-13, 2007. Westin Gateway Hotel, Arlington Virginia. Hosted by the National Nanomanufacturing Network. Available from: http://128.119.56.118/ ~nnn01/Workshop.html. Last access: February 2010.
27. Lopez-Alonso V, Hermosilla-Gimeno I, Lopez-Campos G, Maojo V, Martin-Sanchez FJ. Action GRID: assessing the impact of Nanotechnology on biomedical informatics. AMIA Annu Symp Proc 2008. p 1046.
28. Thomas DG, Pappu RV, Baker NA. Ontologies for cancer nanotechnology research. Engineering in Medicine and Biology Society, 2009. EMBC 2009. Annual International Conference of the IEEE, Sept. 3-4, 2009. pp 4158-4161.
29. caBIG Nanotechnology Working Group, National Cancer Institute. Nanomedicine Ontology and Vocabulary (homepage on the internet). Available from: http://sites.google.com/site/cabignanowg/ ontology-development-and-governance. Last access: February 2010.
30. FHDA and NASA. Atlas of Nanotechnology (homepage on the internet). Available from: http:// nanosense.org/documents/nanoed05/AtlasOf Nanotechnology.pdf. Last access: February 2010.
31. Groen PJ, Wine M, Goldstein D. Implantable Medical Devices and EHR Systems. Virtual Medical records. 2007. Available from: http://www.hoise. com/vmw/07/articles/vmw/LV-VM-06-07-5.html.
32. Network for Computational Nanotechnology, National Science Foundation. NanoHub (homepage on the internet). Available from: http:// nanohub.org/. Last access: February 2010.
33. Towards Virtual Physiological Human: Multilevel modeling and simulation of the human anatomy and physiology. White Paper edited by DG INFSO & DG JRC-November 2005. Available from: http://europa.eu.int/information_society/ activities/health/docs/events/barcelona2005/ecvph-white-paper2005nov.pdf.
34. Clapworthy G, Kohl P, Gregerson H, Thomas S, Viceconti M, Hose D, et al. Digital Human Modelling: A Global Vision and a European Perspective. In: Digital Human Modelling: A Global Vision and a European Perspective. Berlin: Springer; 2007. pp 549-558.
35. ACTION-Grid FP7 EC-funded Support Action. ACTION-Grid (homepage on the internet). Available from: http://www.vph-action-grid.eu. Last access: February 2010.
36. Maojo V, Martin-Sanchez F, Kulikowski C, Rodriguez-Paton A, Fritts M. Nanoinformatics and DNABased Computing: Catalyzing Nanomedicine. Pediatr Res 2010. (Epub ahead of print).
37. De la Iglesia D, Chiesa S, Kern J, Maojo V, Martin-Sanchez F, Potamias G, Moustakis V, Mitchell JA. Nanoinformatics: new challenges for biomedical informatics at the nano level. Stud Health Technol Inform 2009; 150: 987-991.
38. Chiesa S, De la Iglesia D, Crespo J, Martin-Sanchez F, Kern J, Potamias G, Maojo V. European efforts in nanoinformatics research applied to nanomedicine. Stud Health Technol Inform 2009; 150: 757-761.
39. De la Calle G, Garcia-Remesal M, Maojo V. A method for indexing biomedical resources over the internet. Stud Health Technol Inform 2008; 136: 163-168.
40. De la Calle G, Remesal MG, Chiesa S, de la Iglesia D, Maojo V. BIRI: a new approach for automatically discovering and indexing available public bioinformatics resources from the literature. BMC Bioinformatics 2009; 10 (1): 320+.
41. Chiesa S, García-Remesal M, de la Calle G, de la Iglesia D, Bankauskaite V, Maojo V. Building an Index of Nanomedical Resources: An Automatic Approach Based on Text Mining. Proc of the KES2008 (2). 2008. pp 50-57.
42. Rosamund D, et al. Insight: Lab on a chip. Nature 2006; 442 (7101): 367-418.
43. Yager P, Edwards T, Fu E, Helton K, et al. Microfluidic diagnostic technologies for global public health. Nature 2006; 442: 412-418.
44. Morris SK, Coombes KR, Koomen J, et al. Feature extraction and quantification for mass spectrometry in biomedical applications using the mean spectrum. Bioinformatics 2005; 21: 1764-1775.
45. Yanagisawa K, Shyr Y, Xu BJ, et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 2003; 362: 433-439.
46. Gorelik E, Landsittel DP, Marrangoni AM, Modugno F, Velikokhatnaya L, Winans MT, et al. Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 981-987.
47. Mischak H, Banks RE, Conaway M, Coon J, Dominiczak A, Ehrich JHH, Fliser D, et al. Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics Clinical Applications 2007; 1: 148-156.
48. LOCCANDIA FP6 EC-funded Project. LOCCANDIA (homepage on the internet). Available from: http://www.loccandia.eu. Last access: February 2010.
49. Jordan B, et al. LOCCANDIA: Lab-on-Chip Based Protein Profiling for Cancer Diagnosis. In: Proc pHealth: International Workshop on Wearable Micro and Nanosystems for Personalised Health (full paper). Valencia, Spain, May 21-23, 2008.
50. Kalaitzakis M, Kritsotakis V, Kondylakis H, Potamias G, Tsiknakis M, Kafetzopoulos D. An Integrated Clinico-Proteomics Information Management and Analysis Platform. In: Proc 21st IEEE International Symposium on Computer-Based Medical Systems (CBMS 2008), University of Jyväskylä, Finland, pp 218-220. ISBN/ISSN: 1063-7125, 978-0-7695-3165-6.
51. Paulus C, Bonnet S, Gerfault L, Mery E, Strubel G, Ricoul F, Grangeat P. Chromatographic alignment combined with chemometrics profile reconstruction approaches applied to LC-MS data. In: Proc 29th Annual International Conference of the IEEE EMBS (EMBC 2007), August 23-26, 2007, Lyon, France. pp 5983-5986.
52. Pedrioliet PG. A common open representation of mass spectrometry data and its application to proteomics research. Nat Biotechnol 2004; 22 (11): 1459-1466.
53. Lin SM, Zhu L, Winter AO, Sasinowski M, Kibbe WA. What is mzXML good for? Proteomics (Expert review) 2005; 2 (6): 839-845.
54. Lopez-Campos G, Coiras M, Sanchez-Merino JP, Lopez-Huertas MR, Spiteri I, Martin-Sanchez F, Perez-Brena P. Oligonucleotide microarray design for detection and serotyping of human respiratory adenoviruses by using a virtual amplicon retrieval software. J Virol Methods 2007; 145 (2): 127-136.
55. BussuB software, Institute of Health "Carlos III". Madrid (Spain) (homepage on the internet). Available from: http://ibsen.tic.udc.es/bussubWeb2/. Last access: August 2010.
56. Lopez-Campos GH, Garcia-Albert L, Martin-Sanchez F, Garcia-Saiz A. Analysis and management of HIV peptide microarray experiments. Methods Inf Med. 2006; 45 (2): 158-162. Available from: http:// www.schattauer.de/en/magazine/subject-areas/ journals-a-z/methods/contents/archive/issue/677/ manuscript/5942.html. Last access: August 2010.
57. BRB-ArrayTools, Biometric Research Branch, National Cancer Institute (homepage on the internet). Available from: http://linus.nci.nih.gov/BRBArrayTools. html. Last access: August 2010.
58. Martín-Sanchez F, López-Alonso V, Hermosilla-Gimeno I, Lopez-Campos G. A Primer in Knowledge Management for Nanoinformatics in Medicine. In: Proc KES 2008. Lecture Notes in Computer Science 2008; 5178: 50-57.
59. López-Alonso V, Moreno-López L, López-Campos G, Maojo V, Martin-Sanchez F. Description of an Ontology for supporting BIKMAS, a Biomedical Informatics Knowledge Management System. In: Proc KES 2002. IOS Press 2002. pp 955-959.
60. COMBIOMED Thematic Network. Red COMBIOMED (homepage on the internet). Available from: http://combiomed.isciii.es. Last access: February 2010.
61. European Commission. Nanosciences, Nanotechnologies, Materials and new Production Technologies (homepage on the Internet). Available from: http://ec.europa.eu/research/fp7/index_en.cfm?pg =nano. Last access: February 2010.
62. European Technology Platform. ETP Nanomedicine (homepage on the Internet). Available from: http://www.etp-nanomedicine.eu/. Last access: February 2010.
63. Strategic Research Agenda for NanoMedicine. European Technology Platform on NanoMedicine. November 2006. Available from: ftp://ftp. cordis.europa.eu/pub/nanotechnology/docs/ nanomedicine_bat_en.pdf.
64. SHARE FP6 EC-funded Project. The SHARE Road-Map (homepage on the Internet). Available from: http://eu-share.org/roadmap/SHARE_roadmap_ long.pdf. Last access: February 2010.
65. EGEE FP7 EC-funded Project. EGEE Enabling Grids for E-SciencE (homepage on the Internet). Available from: http://www.eu-egee.org/. Last access: February 2010.
66. DEISA FP7 e-INFRASTUCTURE EC-funded Project. DEISA (Distributed European Infrastructure for Supercomputing Applications) (homepage on the Internet). Available from: http://www.deisa.eu/. Last access: February 2010.
67. NorduGrid. NorduGrid: Grid Solution for Wide Area Computing and Data Handling. (homepage on the Internet). Available from: http://www. nordugrid.org/. Last access: February 2010.
68. National Science Foundation and the U.S. Department of Energy's Office of Science. OSG (Open Science Grid) (homepage on the Internet). Available from: http://www.opensciencegrid.org/. Last access: February 2010.
69. National Cancer Institute, US National Institutes of Health. caBIG: cancer Biomedical Informatics Grid (homepage on the Internet). Available from: https://cabig.nci.nih.gov/. Last access: February 2010.
70. European Council. ESFRI: European Strategy Forum on Research Infrastructures (homepage on the Internet). Available from: http://cordis.europa. eu/esfri/. Last access: February 2010.
71. Saltz J, Oster S, Hastings S, et al. caGrid: design and implementation of the core architecture of the cancer biomedical informatics grid. Bioinformatics 2006; 22 (15): 1910-1916.
72. Nanotechnology Characterization Laboratory, National Cancer Institute, US National Institutes of Health. caNanoLab: cancer Nanotechnology Laboratory (homepage on the Internet). Available from: http://cananolab.abcc.ncifcrf.gov/ caNanoLab/. Last access: February 2010.
73. Baker NA, Fritts M, Guccione S, Paik DS, Pappu RV, Patri A, Rubin D, Shaw SY, Thomas DG. Nanotechnology Informatics White Paper. caBIG, National Cancer Institute. February 2009. Non-peer Reviewed Manuscript.
74. Alliance for NanoHealth (ANH). Alliance for NanoHealth (homepage on the Internet). Available from: http://www.nanohealthalliance.org/. Last access: February 2010.
75. National Institutes of Health. The NIH Common Fund: National Network of Nanomedicine Development Centers (homepage on the Internet). Available from: http://nihroadmap.nih.gov/ nanomedicine/fundedresearch.asp. Last access: February 2010.
76. Asia Pacific Nanotechnology Forum (homepage on the internet). Available from: http://www.apnf.org. Last access: August 2010.
77. Science and Technology Basic Plan, Japanese Council for Science and Technology Policy (homepage on the internet). Available from: http://www8.cao.go. jp/cstp/english/basic/. Last access: August 2010.
78. Anon (2007). Report on Mid-and Long-term Research and Development Strategy for Nanotechnology/Materials Science in Japan. Available at: http://www.nanonet.go.jp/english/info/report/ rep20060628.html.
79. Nanotechnology Researchers Network Center of Japan (homepage on the internet). Available from: http://www.nanonet.go.jp/english. Last access: August 2010.
80. Center for Nano-Bio Integration at the University of Tokyo (homepage on the internet). Available from: http://park.itc.u-tokyo.ac.jp/CNBI/e/index. html. Last access: August 2010.
81. Maojo V, Kulikowski C. Medical informatics and bioinformatics: integration or evolution through scientific crises? Methods Inf Med 2006; 45 (5): 474-482.
82. Kuhn KA, Knoll A, Mewes HW, Schwaiger M, et al. Informatics and medicine-from molecules to populations. Methods Inf Med 2008; 47 (4): 283-295.
83. Altman RB, Balling R, Brinkley JF, Coiera E, et al. Commentaries on "Informatics and medicine: from molecules to populations". Methods Inf Med 2008; 47 (4): 296-317.
84. Maojo V, Kulikowski CA. Reflections on biomedical informatics: from cybernetics to genomic medicine and nanomedicine. Stud Health Technol Inform 2006; 124: 19-24.
85. Mantas J, Ammenwerth E, Demiris G, Hasman A et al.; IMIA Recommendations on Education Task-Force. Recommendations of the International Medical Informatics Association (IMIA) on Education in Biomedical and Health Informatics. First Revision. Methods Inf Med 2010; 49 (2): 105-120.
86. European Commission. Nanosciences, Nanotechnologies, Materials and new Production Technologies Calls: FP7-NMP-2010-EU-USA (homepage on the Internet). Available from: http://cordis. europa.eu/fp7/dc/index.cfm?fuseaction=UserSite. CooperationDetailsCallPage&call_id=276. Last access: February 2010.
87. U.S. Environmental Protection Agency. Funding opportunities: Increasing Scientific Data on the Fate, Transport and Behavior of Engineered Nanomaterials in Selected Environmental and Biological Matrices-call EU-USA (homepage on the Internet). Available from: http://www.epa.gov/ncer/rfa/2010/ 2010_star_ nano.html. Last access: February 2010.